Yizhe Chen

Years Active: 2017-2024
Publications (10 Years): 3

University of Kentucky

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Kentucky Oct 01 2016

United States

Scientist II :: Pharmaceutic Science

Publications

Ming Chang, Yizhe Chen, Ken Ogasawara, Brian James Schmidt, Lu Gaohua
Advancements in physiologically based pharmacokinetic modeling for fedratinib: updating dose guidance in the presence of a dual inhibitor of CYP3A4 and CYP2C19. Cancer chemotherapy and pharmacology (2024)
Yizhe Chen, David Wyatt, Massimo Attanasio, Mark Thomas, Michael Thomas, Bing He, Rina Nishii, Liangang Liu, Vivian Shan, Yongjun Xue, Leonidas N Carayannopoulos, Ken Ogasawara, Gopal Krishna
Relative bioavailability of fedratinib through various alternative oral administration methods in healthy adults. Cancer chemotherapy and pharmacology (2023)
Daniel C Scott, Jared T Hammill, Jaeki Min, David Y Rhee, Michele Connelly, Vladislav O Sviderskiy, Deepak Bhasin, Yizhe Chen, Su-Sien Ong, Sergio C Chai, Asli N Goktug, Guochang Huang, Julie K Monda, Jonathan Low, Ho Shin Kim, Joao A Paulo, Joe R Cannon, Anang A Shelat, Taosheng Chen, Ian R Kelsall, Arno F Alpi, Vishwajeeth Pagala, Xusheng Wang, Junmin Peng, Bhuvanesh Singh, J Wade Harper, Brenda A Schulman, R Kiplin Guy
Blocking an N-terminal acetylation-dependent protein interaction inhibits an E3 ligase. Nature chemical biology 13 (8) (2017)

Yizhe Chen.css-eqlu8i{font-size:small;padding-left:4px;}